Table 12.11a

Adjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	2,010	89.7%	0.7%	2,010	80.2%	0.9%	1,765	61.3%	1.2%	1,689	45.5%	1.3%
Primary Diagnosis	Emphysema/COPD	866	92.7%	0.9%	866	84.8%	1.3%	779	65.8%	1.9%	664	48.8%	2.1%
	Cystic Fibrosis	301	91.4%	1.8%	301	81.1%	2.7%	292	59.0%	3.8%	297	44.7%	3.7%
	Idiopathic Pulmonary Fibrosis	366	87.8%	1.7%	366	76.1%	2.3%	279	54.2%	3.1%	260	39.1%	3.1%
	Alpha-1-Antitrypsin Deficiency	160	88.9%	2.5%	160	74.9%	3.5%	134	57.5%	4.4%	160	46.1%	4.2%
	Primary Pulmonary Hypertension	81	73.6%	5.1%	81	69.6%	5.4%	75	54.1%	6.1%	88	39.0%	5.7%
	Congenital Disease	16	73.9%	11.2%	16	73.9%	11.2%	30	55.8%	9.6%	29	35.2%	9.2%
	Other	220	85.4%	2.5%	220	74.0%	3.1%	175	63.2%	3.8%	189	47.6%	4.0%
	Unknown	0	-	-	0	-	-	1	+	+	2	53.8%	23.7%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.